1. "Molecular Imaging and Therapy Service"
  2. "American Society of Hematology"
  3. "Sergio Giralt"
Formats
  1. Meeting Abstract (7)
Groups
  1. Bone Marrow Transplant (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Molecular Imaging and Therapy Service (7)
  6. Radiology, Department of (7)

More Groups

People
  1. Sergio Giralt (7)
  2. Michael Scordo (5)
  3. Sean Devlin (5)
  4. Gunjan Shah (4)
  5. Miguel-Angel Perales (3)
  6. Parastoo Dahi (3)

More People

Years
  1. 2023 (3)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2017 (1)
Publications
  1. Blood (7)
Publishers
  1. American Society of Hematology (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Post-transplant pain and paralysis: Neurologic amyotrophy as an atypical cause of shoulder dysfunction following hematopoietic stem cell transplant
    Meeting Abstract

    Davidoff, C.; Ibanez, K.; Hwang, S.; Goldstein, I.; Feldman, D. R.; Gyurkocza, B.; Giralt, S. A.; Politikos, I.; Ponce, D. M.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in combination with multi-morbidity and functional impairment
    Meeting Abstract

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Elko, T. A.; Ruiz, J. D.; Sauter, C. S.; Dahi, P. B.; Maloy, M. A.; Perales, M. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Characterizing ionizing radiation exposure after T-cell depleted allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Cho, C.; Maloy, M.; Devlin, S. M.; Aras, O.; Castro-Malaspina, H. R.; Dauer, L. T.; Jakubowski, A. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Perales, M. A.; more...
    Blood (2017)

    Fulltext@MSK | Save